Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG).
Kastritis E, Katodritou E, Badelita S, Bila J, Seval GC, Cvetkovic Z, Coriu D, Spanoudakis E, Dalampira D, Sretenovic A, Sevastoudi A, Bojan A, Mitrovic M, Danaila C, Gavriatopoulou M, Roussou M, Charalampous C, Terpos E, Beksac M, Dimopoulos MA. Kastritis E, et al. Among authors: charalampous c. Leuk Lymphoma. 2024 Dec;65(13):2064-2067. doi: 10.1080/10428194.2024.2391900. Epub 2024 Aug 14. Leuk Lymphoma. 2024. PMID: 39141607 No abstract available.
Malignant Pericardial Effusion: A Systematic Review.
Mudra SE, Rayes D, Kumar AK, Li JZ, Njus M, McGowan K, Charalampous C, Kalam KA, Syed A, Majid M, Schleicher M, Agrawal A, Yesilyaprak A, Klein AL. Mudra SE, et al. Among authors: charalampous c. CJC Open. 2024 May 15;6(8):967-972. doi: 10.1016/j.cjco.2024.05.003. eCollection 2024 Aug. CJC Open. 2024. PMID: 39211754 Free PMC article. Review.
Retreatment of multiple myeloma with previously refractory drugs.
Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder A, Gertz MA, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame RM, Kyle RA, Rajkumar SV, Kumar SK. Goel U, et al. Among authors: charalampous c. Blood Adv. 2024 Dec 24;8(24):6321-6328. doi: 10.1182/bloodadvances.2024014723. Blood Adv. 2024. PMID: 39536293 Free PMC article.
Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies.
Charalampous C, Goel U, Kapoor P, Binder M, Buadi F, Dingli D, Dispenzieri A, Fonder A, Gertz M, Gonsalves W, Hayman S, Hobbs M, Hwa YL, Kourelis T, Lacy M, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar V, Kumar SK. Charalampous C, et al. Clin Lymphoma Myeloma Leuk. 2024 Oct;24(10):e329-e335. doi: 10.1016/j.clml.2024.05.020. Epub 2024 Jun 1. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38955580
Immune checkpoint inhibitors and pericardial disease: a systematic review.
Mudra SE, Rayes DL, Agrawal A, Kumar AK, Li JZ, Njus M, McGowan K, Kalam KA, Charalampous C, Schleicher M, Majid M, Syed A, Yesilyaprak A, Klein AL. Mudra SE, et al. Among authors: charalampous c. Cardiooncology. 2024 May 17;10(1):29. doi: 10.1186/s40959-024-00234-0. Cardiooncology. 2024. PMID: 38760863 Free PMC article.
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder A, Gertz MA, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame RM, Kyle RA, Rajkumar SV, Kumar SK. Goel U, et al. Among authors: charalampous c. Blood Cancer J. 2024 Mar 26;14(1):55. doi: 10.1038/s41408-024-01039-1. Blood Cancer J. 2024. PMID: 38531841 Free PMC article.
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
Charalampous C, Goel U, Kapoor P, Binder M, Buadi FK, Cook J, Dingli D, Dispenzieri A, Fonder AL, Gertz MA, Gonsalves W, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar SV, Kumar SK. Charalampous C, et al. Blood Cancer J. 2023 Dec 11;13(1):183. doi: 10.1038/s41408-023-00957-w. Blood Cancer J. 2023. PMID: 38072941 Free PMC article. No abstract available.
43 results